Innovating Works

Cancer-Drug-Screen

financed
High throughput drug screening for identifying personalized cancer treatments ta...
High throughput drug screening for identifying personalized cancer treatments tailored to the particular mutations of the patient s tumor Cancer is caused by a series of genetic alterations that confer an advantage to cancer cells, leading to uncontrolled growth. However, each tumor exhibits distinct molecular changes, making each patient’s malignancy unique. Hence,... see more
30/09/2016
WEIZMANN
150K€
Project Budget: 150K€
see more

Project leader
WEIZMANN INSTITUTE OF SCIENCE No se ha especificado una descripción o un objeto social para esta compañía.
TRL 4-5
PARTICIPATION DEPralty Sin fecha límite de participación.
Financing granted El organismo H2020 notifico la concesión del proyecto The day 2016-09-30
ERC-PoC-2014: ERC Proof of Concept Grant Scope:Objectives
Cerrada does 11 years
0% 100% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.